When tesamorelin is a new word
Tesamorelin specialist?Start with the words.
Understand the medicine, what care involves and what to ask at a visit.
The Food and Drug Administration (FDA) handles US reviews of medicines for specific uses.
As of September 28, 2026, tesamorelin has US approval to reduce excess belly fat in adults with HIV who have lipodystrophy.
Lipodystrophy means the pattern of fat across the body has changed.
Its label says it is not a treatment for weight loss.
Begin with the purpose
More specific than “belly fat.”
Adults with HIV
A change in body fat
Excess belly fat
What kind of care am I looking for?
You can compare care at a distance, called telehealth, with an in-person clinic. Ask each service how it would assess your concern, arrange tests and handle follow-up. Ask for the doctor’s name so you can check their licence.
Find a word, find a question
What does that mean?
All terms are shown.
Tesamorelin
A lab-made medicine that prompts the body to release growth hormone.
Lipodystrophy
A change in how fat is spread around the body.
Visceral fat
Fat deep inside the belly, around the organs.
Growth hormone
A chemical signal produced inside the body; tesamorelin prompts more of it to be released.
Growth factor
IGF-1 is a chemical message that helps cells grow; tesamorelin raises its level in the blood.
Approved use
The named use covered by a medicine’s approval.
Off-label
Using a medicine for a purpose outside its approved use.
Biologic
A group of medicines with separate licensing rules; making a tesamorelin copy at a pharmacy is not lawful.
Compounding
Making a medicine to order; US rules prohibit pharmacy-made copies of tesamorelin.
Telehealth
Care discussed at a distance, with checks that still matter.
Licence
A record to check with the board that oversees the doctor or pharmacy.
No word matches yet. Try a shorter word, or clear the search to see all terms.
Ready to turn words into a conversation?
Keep a place for the purpose, the plan and the price.
Read the source notes
Source-check dates: September 17, 2026 / September 26, 2026 / September 28, 2026.
- DailyMed: the tesamorelin (EGRIFTA WR) label
- FDA: tesamorelin approval and licence record
- FDA: questions and answers on compounding
- Look up your state’s medical board
- FDA: find your state pharmacy licence search
- Federation of State Medical Boards: policy on remote care
The medical boards’ policy is guidance; the binding rules come from the state.
Ask for confirmation of the current product, rules and costs before deciding on care.